drugset / Trial / NCT07231185

Phase 2 Efficacy Study of Sildenafil Products in Adult Men With Erectile Dysfunction

NCT07231185 ↗

Phase 2 Not yet recruiting 200 enrolled Aspargo Labs, Inc
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The goal of this clinical trial is to learn how different sildenafil-based erectile dysfunction (ED) treatments affect erectile function in adult men. The main questions it aims to answer are: Does each assigned product improve erectile function over 12 weeks? What safety or tolerability issues occur when these products are used on an on-demand basis? Researchers will compare Hezkue® and Hezkue Turbo® with several commercially available sildenafil or sildenafil-plus-tadalafil products to see whether there are differences in effectiveness, treatment experience, or safety. Participants will: * Use one assigned ED treatment on demand for 12 weeks * Complete electronic diaries and questionnaires about sexual-encounter outcomes and treatment satisfaction * Attend study visits for safety checks, laboratory tests, and assessments of erectile function

Timeline

Start
2026-01
Primary completion
2026-03
Completion
2026-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aristo Sildaristo Unknown — Oral
Comparator BlueChew Unknown — Oral
Comparator Galotam Unknown — Oral
Subject Hezkue Unknown — Oral
Subject Hezkue Turbo Unknown — Oral
Comparator Lemonaid Health Sildenafil Unknown — Oral
Comparator Pfizer Viagra Unknown — Oral
Comparator Sildenafil Unknown — Oral
Comparator Tadalafil Small molecule — Oral

Indications